ClinicalTrialsFinder
RecruitingNCT07558889

The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population

The ENDOCancer-DATA: the Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

10,000 participants

Start Date

Apr 1, 2024

Study Type

OBSERVATIONAL

Conditions

Gynecologic CancerEndometrium Cancer

Summary

The aim of this study is to lay the bases for an ambitious project that reports and records all the epidemiological-clinical information of the cases of endometrial carcinoma diagnosed and treated in the reference oncology centers involved on the national territory, to create a process of analysis of the data

Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria5

  • diagnosis of endometrial cancer (stage I-IV, G1-3, and special histotypes)
  • age > 18 years
  • American Society of Anesthesiologists classification (ASA score) 1-3
  • patients undergoing staging, cytoreduction or diagnostic surgery with acquisition of histological examination on which IHC and/or NGS studies have been performed for the molecular profile of the carcinoma
  • Signed informed consent

Exclusion Criteria3

  • patients with missing information
  • patients not treated in the participating centers for which only partial and fragmented information will be available
  • molecular profile not known and\\or not recoverable and retrospectively analysable

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Fondazione Policlinico Universitario Agostino Gemelli, IRCCS

Roma, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07558889

Related Trials

CARE Tool Study Aim 3

NCT072968873 locations

BOLSTER: Learning New Skills to Thrive

NCT069368782 locations

Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients

NCT067287091 location

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

NCT055598791 location

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

NCT075241141 location